| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |